The global Automated Breast Ultrasound Systems Market is projected to expand at approximately 10% CAGR during the forecast period of 2021-2031. Increasing necessity of early detection of breast cancer and accurate diagnostic reports is promoting leading players to develop modern automated diagnosis systems.

Request a report sample with 92 pages to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-606

According to the World Health Organization (WHO), 2.3 million women were diagnosed with breast cancer in 2020, and 685,000 succumbed to the disease globally. Breast cancer is the most prevalent type of cancer in the world, occurring in every country, affecting women of any age after puberty, with slowly increasing rates in adulthood.

Initiatives taken by various governmental and non-governmental bodies such as National Breast Cancer Awareness month are anticipated to positively impact the demand for automated breast ultrasound systems for the early screening of tumors in dense breast tissue.

Surging cases of breast cancer are also being attributed to increasingly sedentary lifestyle and obesity. The implementation of high-frequency sound waves to map breast for creating 3D monochromatic images of tissue and the breast structure is propelling the demand in the market, finds ESOMAR-certified consulting firm FMI in this study.

3D automated breast ultrasound systems have witnessed major progress in the market, especially when they are combined with full-field digital screening mammography (FFDSM). These systems deliver higher accuracy in invasive breast cancer diagnosis and have higher recall features and are gaining popularity in the automated breast ultrasound systems market.

Due to the COVID-19 outbreak, a slight drop in demand was observed in 2020. The stringent lockdown restrictions compelled doctors to limit the breast ultrasound procedures for critical patients only.

Skilled professionals were required to prioritize COVID-19 patients to break the transmission chain of the virus, thus restricting the market demand. Nonetheless, FMI anticipates a strong recovery in the automated breast ultrasound market as cases of breast cancer are surging globally.

According to FMI’s analysis, North America is currently leading in the automated breast ultrasound systems market. Growth in this region can be attributed to rising cases of breast cancer, coupled with robust healthcare infrastructure and increasing research and development in terms of advancements in the digital cancer screening systems.

“The implementation of automated breast ultrasound systems with other technologically advanced cancer screening operations will yield highly accurate results, thereby promoting the rapid adoption of ABUS in diagnostic laboratories and augmenting the market growth,” remarks an FMI analyst.

Discover more about the automated breast ultrasound systems market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on https://www.futuremarketinsights.com/ask-question/rep-gb-606

Key Takeaways

  • The U.S. is dominating the North America automated breast ultrasound systems market due to the rising incidence of breast cancer, coupled with increasing government initiatives regarding awareness of the same among women.
  • In terms of end-user, hospitals are leading the automated breast ultrasound systems.
  • India will provide lucrative opportunities for growth due to increasing per capita income and rising cases of breast cancer in the country.
  • Europe is anticipated to show steady growth in the automated breast ultrasound systems market due to the prevalence of obesity and growing alcohol abuse. Increasing breast cancer cases also will emerge as a chief growth driver in the U.K.

Prominent Drivers

  • Advent of technologically advances screening systems such as 3D automated breast ultrasound systems will propel the demand in the market.
  • Implementation of breast cancer awareness campaigns across various countries will generate demand for automated breast ultrasound systems.
  • Increasing demand for highly accurate digital screening systems will drive market growth.

Key Restraints

  • High cost of standardized training and lack of skilled radiologists is hindering the market growth.
  • Underdeveloped healthcare infrastructure and lack of awareness in emerging economies are hampering the growth in the market.
  • Inability to display calcification and producing false positive reports will negatively impact sales in the market.

Prominent players operating in the automated breast ultrasound systems market profiled by FMI include:

  • GE Electric Co.
  • Siemens A.G.
  • Hitachi Ltd.
  • SonoCiné Inc.
  • Koninklijke

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-606

More Insights on FMI’s Automated Breast Ultrasound Systems Market

The latest market study on the automated breast ultrasound systems market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to gain a better perspective of the global market potential, its growth, trends, and opportunities, the market is segmented on the basis of:

End User

  • Hospitals
  • Diagnostic Imaging Laboratories

Explore Other Reports Links from Healthcare Market

Pipette Controller Market:- Pipette Controller demand is anticipated to be valued at US$ 190 Million in 2022, forecast to grow at a CAGR of 4.6% to be valued at US$ 300 Million from 2022 to 2032.

Automated Cannabis Testing Market:- Automated Cannabis Testing is an advanced integrated information system for the management of all the aspects involved in operations such as financial, medical, administrative, legal, and compliance.

Veterinary Glucometers Market:- Veterinary Glucometers are used to determine the glucose level in the companion animals. The veterinary glucometers are specially used for the dogs and cats.

Cholesterol Monitors Market:- In 2022, it is anticipated that the Cholesterol Monitors Market is valued US$ 2,514.6 million. The cholesterol monitors market is expected to expand at a 7.4% CAGR from 2022 to 2032 and is likely generate US$ 4,502.4 million.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Leave a comment

Your email address will not be published. Required fields are marked *